Drug Classification · Questions 1–6
Identify the pharmacological class or categorical label for each drug or receptor. Vocabulary preparation is sufficient to answer every question in this section.
Question 1
Amlodipine is classified as which type of calcium channel blocker?
Correct Answer
A) Dihydropyridine
Rationale
Amlodipine belongs to the dihydropyridine class of calcium channel blockers.
Question 2
Verapamil is classified as which type of calcium channel blocker?
Correct Answer
B) Non-dihydropyridine
Rationale
Verapamil belongs to the non-dihydropyridine class of calcium channel blockers.
Question 3
Diltiazem is classified as which type of calcium channel blocker?
Correct Answer
C) Non-dihydropyridine
Rationale
Diltiazem belongs to the non-dihydropyridine class of calcium channel blockers.
Question 4
Immediate-release nifedipine is classified as which type of calcium channel blocker?
Correct Answer
D) Dihydropyridine
Rationale
Immediate-release nifedipine belongs to the dihydropyridine class of calcium channel blockers.
Question 5
Verapamil is classified as commonly producing which adverse gastrointestinal effect?
Correct Answer
A) Constipation
Rationale
Constipation is classified as a common adverse effect of verapamil, resulting from calcium channel blockade acting on intestinal smooth muscle.
Question 6
Gingival overgrowth is classified as an effect of which drug class?
Correct Answer
B) Calcium channel blockers
Rationale
Gingival overgrowth is classified as a class effect of calcium channel blockers, more common with nifedipine and verapamil.
Core Pharmacology · Questions 7–14
Apply your understanding of drug mechanisms, pharmacokinetics, and adverse effects. Each question requires one reasoning step.
Question 7
Why does blockade of L-type calcium channels in vascular smooth muscle produce vasodilation?
Correct Answer
A) Calcium entry through this channel normally triggers the contraction that maintains vascular tone, so blocking it allows the muscle to relax
Rationale
In vascular smooth muscle, calcium entry through L-type channels triggers the contraction that maintains vascular tone. Blocking the channel prevents this calcium entry, causing the muscle to relax and producing vasodilation.
Question 8
Why do dihydropyridine calcium channel blockers produce minimal effect on heart rate while non-dihydropyridines meaningfully slow it?
Correct Answer
C) Dihydropyridines are highly vascular-selective, while non-dihydropyridines have balanced effects on both vascular and cardiac tissue
Rationale
Although all calcium channel blockers act on the same L-type channel, dihydropyridines are highly vascular-selective, producing vasodilation with minimal direct effect on heart rate or contractility. Non-dihydropyridines have much more balanced effects on both vascular and cardiac tissue.
Question 9
Why does amlodipine produce little to no reflex tachycardia, while immediate-release nifedipine produces pronounced reflex tachycardia?
Correct Answer
B) Amlodipine binds and releases from the calcium channel slowly, so the gradual blood pressure fall does not strongly trigger the baroreceptor reflex
Rationale
Amlodipine binds to and releases from the calcium channel slowly, producing a gradual onset of vasodilation. Because the blood pressure fall happens slowly rather than abruptly, the baroreceptor reflex is not strongly triggered, unlike with the rapid onset of immediate-release nifedipine.
Question 10
Why do verapamil and diltiazem not produce reflex tachycardia despite causing peripheral and coronary vasodilation?
Correct Answer
D) Vasodilation and direct heart rate reduction occur together rather than separately, so heart rate tends to fall or stay unchanged rather than rise
Rationale
Because verapamil and diltiazem act on cardiac tissue as well as vascular tissue, they produce direct negative chronotropy alongside vasodilation. Since vasodilation and heart rate reduction happen together rather than separately, these agents do not produce the reflex tachycardia seen with short-acting dihydropyridines.
Question 11
Why is combining a beta-blocker with a non-dihydropyridine calcium channel blocker generally avoided in routine practice?
Correct Answer
A) Both drug classes independently suppress sinoatrial node automaticity and atrioventricular nodal conduction, producing additive suppression
Rationale
Beta-blockers and non-dihydropyridine calcium channel blockers both independently suppress sinoatrial node automaticity and atrioventricular nodal conduction. Combining them produces additive, potentially severe suppression of the heart's own conduction system, risking profound bradycardia or complete heart block.
Question 12
Why does dihydropyridine-induced peripheral edema occur even though these drugs do not cause sodium or fluid retention?
Correct Answer
C) Arteriolar dilation occurs without a matching degree of venodilation, raising capillary pressure and pushing fluid into surrounding tissue
Rationale
The mechanism of dihydropyridine-induced edema is purely hemodynamic. Arteriolar dilation occurs without a matching degree of venodilation, raising pressure in the capillary bed and pushing fluid into the surrounding tissue, which is why this edema does not respond to a diuretic the way fluid-overload edema would.
Question 13
Why are verapamil and diltiazem contraindicated in heart failure with reduced ejection fraction, while amlodipine is considered safe in this population?
Correct Answer
B) Verapamil and diltiazem meaningfully reduce contractility, further impairing a heart muscle that is already failing, while amlodipine has minimal effect on contractility at therapeutic doses
Rationale
Because verapamil and diltiazem meaningfully reduce contractility, reducing the calcium available for contraction further impairs a heart muscle that is already failing. Amlodipine, by contrast, has minimal effect on contractility at therapeutic doses, which is a direct consequence of the tissue-selectivity difference between the two subclasses.
Question 14
Why do verapamil and diltiazem carry potential for clinically relevant drug interactions with many other commonly used medications?
Correct Answer
D) They are metabolized through the same hepatic enzyme pathway responsible for metabolizing many other commonly used drugs
Rationale
Both verapamil and diltiazem are metabolized through the same hepatic enzyme pathway responsible for metabolizing many other commonly used drugs, so both carry potential for clinically relevant drug interactions that should be considered when either is added to a patient's regimen.
Clinical Correlations · Questions 15–18
Apply pharmacological knowledge to clinical scenarios. Each vignette presents a patient situation; the question tests mechanism of action or drug selection.
Question 15
A 62-year-old man with stable angina and moderate persistent asthma cannot tolerate a beta-blocker because of bronchospasm. His physician starts amlodipine instead. Which of the following best explains why amlodipine is an appropriate choice for this patient?
Correct Answer
C) Amlodipine reduces afterload and produces coronary vasodilation without any bronchoconstrictive effect
Rationale
Amlodipine produces afterload reduction through peripheral arterial dilation and direct coronary vasodilation, providing anti-ischemic benefit. Because dihydropyridines have no bronchoconstrictive effect, amlodipine is a useful alternative when beta-blockers are contraindicated by significant respiratory disease.
Question 16
A 55-year-old woman started on amlodipine for stable angina two weeks ago now has mild bilateral ankle swelling. Her renal function is normal, and she has no history of heart failure. A diuretic trial does not improve the swelling. Which of the following best explains the mechanism of her edema?
Correct Answer
A) Arteriolar dilation without a matching degree of venodilation has raised capillary pressure, pushing fluid into surrounding tissue
Rationale
Dihydropyridine-induced peripheral edema is purely hemodynamic in mechanism. Arteriolar dilation occurs without a matching degree of venodilation, raising capillary pressure and pushing fluid into surrounding tissue, which is why it does not respond to a diuretic the way fluid-overload edema would.
Question 17
A 64-year-old man on metoprolol for stable angina continues to have symptoms despite an adequate dose. His physician is considering adding a calcium channel blocker and must choose between a dihydropyridine and a non-dihydropyridine. Which class is the appropriate addition, and why?
Correct Answer
D) A dihydropyridine, because it avoids the additive suppression of sinoatrial and atrioventricular node function that a non-dihydropyridine would add to the beta-blocker
Rationale
A beta-blocker paired with a dihydropyridine works well because the two drugs act on complementary targets without adding to atrioventricular conduction depression. A beta-blocker paired with a non-dihydropyridine is avoided because both classes independently suppress the same conduction system, risking severe bradycardia or complete heart block.
Question 18
A 70-year-old woman with heart failure with reduced ejection fraction also has stable angina and needs an additional antianginal agent. Her physician selects amlodipine rather than verapamil or diltiazem. Which of the following best explains the reasoning behind this choice?
Correct Answer
B) Amlodipine has minimal effect on contractility at therapeutic doses, while verapamil and diltiazem meaningfully reduce contractility and could further impair an already-failing heart
Rationale
Verapamil and diltiazem meaningfully reduce contractility, and reducing the calcium available for contraction further impairs a heart muscle that is already failing, making them contraindicated in heart failure with reduced ejection fraction. Amlodipine has minimal effect on contractility at therapeutic doses and is considered safe in this population.